Startup Genzada to build new HQ, renovate manufacturing facility in Kansas

Startup drugmaker Genzada Pharmaceuticals said it will build new headquarters in Sterling, KS, and renovate an existing building to house a “small-scale” manufacturing facility and R&D facility.

The company said it expects to create as many as 25 to 30 new jobs in the south-central Kansas town. The expansion for the headquarters is expected to be 10,000-square feet and be completed sometime next year, KWCH12 reported.

"The new space will allow us to continue to expand on achieving our mission, which is to eliminate diseases that induce human suffering,” Jason West, Genzada’s EVP, told the television station.

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

The company plans to seek FDA approval next year for human testing of various pharmaceutical products for rare and hard-to-treat cancers and other medical conditions.

Genzada has conducted studies with a combination of three chemical compounds, including a pair from plant-based material, West said.

-here’s the KWCH12 story

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.

Lonza will build two new manufacturing suites at its Visp, Switzerland site to handle antibody-drug conjugates for an unnamed customer.